Total Clarity Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Total Clarity Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-22	Closed	-$3K	–	557
2022 Q2	$3K	Buy	+22	New	+$2.61K	﹤0.01%	885
2022 Q1	–	Sell	-23	Closed	-$4K	–	514
2021 Q4	$4K	Hold	23	–	–	﹤0.01%	839
2021 Q3	$4K	Buy	+23	New	+$3.87K	﹤0.01%	844
2021 Q2	–	Sell	-22	Closed	-$3K	–	417
2021 Q1	$3K	Buy	+22	New	+$3.49K	﹤0.01%	753
2020 Q1	–	Sell	-58	Closed	-$7K	–	316
2019 Q4	$7K	Buy	+58	New	+$6.47K	0.01%	539

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Total Clarity Wealth Management's IBB Position: Q3 2022 in Review

Total Clarity Wealth Management sold out of iShares Biotechnology ETF (IBB) in Q3 2022, closing a stake of 22 shares — an estimated $3K sold.

Total Clarity Wealth Management first reported a position in IBB in Q4 2019 and held it in 5 quarters. The position peaked at $7K in Q4 2019. 829 funds tracked by Wall St. Rank hold IBB as of Q3 2022.

Total Clarity Wealth Management reported no remaining iShares Biotechnology ETF position as of Q3 2022 after selling out during the quarter.
Total Clarity Wealth Management sold 22 iShares Biotechnology ETF shares in Q3 2022, an estimated $3K.
Total Clarity Wealth Management first reported a position in iShares Biotechnology ETF in Q4 2019 and held it in 5 quarters.
Total Clarity Wealth Management's iShares Biotechnology ETF position peaked at $7K in Q4 2019.
829 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2022.

Based on Total Clarity Wealth Management's 13F filing for Q3 2022, filed 4 Nov 2022.